Chris Parker

机构：Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Guy's and St Thomas' NHS Foundation Trust, Chelsea and Westminster Hospital NHS Foundation Trust, London Cancer, MRC Clinical Trials Unit at UCL, Royal Marsden Hospital, University College London · ORCID：0000-0001-6512-124X

发表论文 420 篇 · 总被引 26447 次 · h-index 70

代表论文

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial (2024 · The Lancet · 被引 76)
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial (2024 · The Lancet · 被引 51)
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047) (2024 · European Urology · 被引 30)
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers (2025 · Cell · 被引 28)
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol (2025 · The Lancet Oncology · 被引 24)
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol (2025 · The Lancet Digital Health · 被引 19)